Literature DB >> 11375065

The role of peripheral T-cell deletion in transplantation tolerance.

A D Wells1, X C Li, T B Strom, L A Turka.   

Abstract

The apoptotic deletion of thymocytes that express self-reactive antigen receptors is the basis of central (thymic) self-tolerance. However, it is clear that some autoreactive T cells escape deletion in the thymus and exist as mature lymphocytes in the periphery. Therefore, peripheral mechanisms of tolerance are also crucial, and failure of these peripheral mechanisms leads to autoimmunity. Clonal deletion, clonal anergy and immunoregulation and/or suppression have been suggested as mechanisms by which 'inappropriate' T-lymphocyte responses may be controlled in the periphery. Peripheral clonal deletion, which involves the apoptotic elimination of lymphocytes, is critical for T-cell homeostasis during normal immune responses, and is recognized as an important process by which self-tolerance is maintained. Transplantation of foreign tissue into an adult host represents a special case of 'inappropriate' T-cell reactivity that is subject to the same central and peripheral tolerance mechanisms that control reactivity against self. In this case, the unusually high frequency of naive T cells able to recognize and respond against non-self-allogeneic major histocompatibility complex (MHC) antigens leads to an exceptionally large pool of pathogenic effector lymphocytes that must be controlled if graft rejection is to be avoided. A great deal of effort has been directed toward understanding the role of clonal anergy and/or active immunoregulation in the induction of peripheral transplantation tolerance but, until recently, relatively little progress had been made towards defining the potential contribution of clonal deletion. Here, we outline recent data that define a clear requirement for deletion in the induction of peripheral transplantation tolerance across MHC barriers, and discuss the potential implications of these results in the context of current treatment modalities used in the clinical transplantation setting.

Entities:  

Mesh:

Year:  2001        PMID: 11375065      PMCID: PMC1088449          DOI: 10.1098/rstb.2001.0845

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  8 in total

Review 1.  PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.

Authors:  Myung-Ja Kwon; Ruiqing Wang; Jian Ma; Zuoming Sun
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

Review 2.  T-cell exhaustion in allograft rejection and tolerance.

Authors:  Edward B Thorp; Christian Stehlik; M Javeed Ansari
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

3.  Isolation and transplantation of different aged murine thymic grafts.

Authors:  Y Maurice Morillon; Fatima Manzoor; Bo Wang; Roland Tisch
Journal:  J Vis Exp       Date:  2015-05-13       Impact factor: 1.355

4.  Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.

Authors:  Wei Zhang; Siyuan Liang; Juan Wu; Anatolij Horuzsko
Journal:  Transplantation       Date:  2008-10-27       Impact factor: 4.939

Review 5.  Pathophysiology of acute graft-versus-host disease: recent advances.

Authors:  Yaping Sun; Isao Tawara; Tomomi Toubai; Pavan Reddy
Journal:  Transl Res       Date:  2007-07-03       Impact factor: 7.012

6.  The impact of T cell intrinsic antigen adaptation on peripheral immune tolerance.

Authors:  Nevil J Singh; Chuan Chen; Ronald H Schwartz
Journal:  PLoS Biol       Date:  2006-10       Impact factor: 8.029

7.  IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice.

Authors:  Lerisa Govender; Jean-Christophe Wyss; Rajesh Kumar; Manuel Pascual; Dela Golshayan
Journal:  Front Immunol       Date:  2017-04-21       Impact factor: 7.561

8.  Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.

Authors:  Julia Yuen-Shan Tsang; Yakup Tanriver; Shuiping Jiang; Shao-An Xue; Kulachelvy Ratnasothy; Daxin Chen; Hans J Stauss; R Pat Bucy; Giovanna Lombardi; Robert Lechler
Journal:  J Clin Invest       Date:  2008-10-09       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.